Thrombocytopenia News and Research

RSS
Thrombocytopenia is a condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues.
Clinical data of pomalidomide for treating patients with multiple myeloma presented at ASH 2010

Clinical data of pomalidomide for treating patients with multiple myeloma presented at ASH 2010

9 Dec 2010
Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

8 Dec 2010
Positive interim results from elotuzumab Phase 1b/2 study in relapsed multiple myeloma

Positive interim results from elotuzumab Phase 1b/2 study in relapsed multiple myeloma

7 Dec 2010
Seattle Genetics and Millennium announce positive data from SGN-35 Phase II trial in relapsed or refractory ALCL

Seattle Genetics and Millennium announce positive data from SGN-35 Phase II trial in relapsed or refractory ALCL

7 Dec 2010
Onyx Pharmaceuticals reports positive Phase 2b 003-A1 study results of carfilzomib for refractory multiple myeloma

Onyx Pharmaceuticals reports positive Phase 2b 003-A1 study results of carfilzomib for refractory multiple myeloma

7 Dec 2010
Data from comparative REVLIMID study in multiple myeloma presented at 52nd ASH

Data from comparative REVLIMID study in multiple myeloma presented at 52nd ASH

7 Dec 2010
Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

7 Dec 2010
Allos Therapeutics reports new analysis of PROPEL trial data of FOLOTYN in patients with refractory PTCL

Allos Therapeutics reports new analysis of PROPEL trial data of FOLOTYN in patients with refractory PTCL

6 Dec 2010
Amgen announces final study results of Nplate in adults with chronic ITP

Amgen announces final study results of Nplate in adults with chronic ITP

6 Dec 2010
Pivotal Phase II study data of romidepsin in relapsed PTCL presented at ASH 2010

Pivotal Phase II study data of romidepsin in relapsed PTCL presented at ASH 2010

6 Dec 2010
Updated Phase 1 study results of FOLOTYN in patients with refractory CTCL presented at ASH 2010

Updated Phase 1 study results of FOLOTYN in patients with refractory CTCL presented at ASH 2010

6 Dec 2010
Alexion Pharmaceuticals reports interim results from phase 1 trial on samalizumab antibody

Alexion Pharmaceuticals reports interim results from phase 1 trial on samalizumab antibody

6 Dec 2010
Positive results from pivotal trial of SGN-35 in refractory Hodgkin lymphoma presented at ASH 2010

Positive results from pivotal trial of SGN-35 in refractory Hodgkin lymphoma presented at ASH 2010

6 Dec 2010
Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

6 Dec 2010
Investigational study data of REVLIMID with rituximab or rituximab-containing regimen in CLL patients presented at ASH

Investigational study data of REVLIMID with rituximab or rituximab-containing regimen in CLL patients presented at ASH

6 Dec 2010
Pivotal PROPEL trial data of FOLOTYN in patients with refractory PTCL reported at ASH Annual Meeting

Pivotal PROPEL trial data of FOLOTYN in patients with refractory PTCL reported at ASH Annual Meeting

6 Dec 2010
Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

2 Dec 2010
Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease

Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease

1 Dec 2010
Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck announces initial results from ISENTRESS Phase III study in HIV-1

29 Nov 2010
New method to generate custom-made platelets from skin cells

New method to generate custom-made platelets from skin cells

23 Nov 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback